Figure 2: The 5' UTR of FANCG cDNA inserts recovered from transfected MMC-resistant EUFA143. Complementation group G lymphoblasts from patient EUFA143 were transfected by electroporation as described ...

Radiation Research, Vol. 131, No. 3 (Sep., 1992), pp. 309-314 (6 pages) The XR-V9B mutant of Chinese hamster V79 cells which exhibits hypersensitivity to ionizing radiation was isolated by the replica ...

The excision repair cross-complementation group 1 (ERCC1) protein is a potential prognostic biomarker of the efficacy of cisplatin-based chemotherapy in non–small-cell lung cancer (NSCLC). Although ...

We retrospectively identified 163 patients with inoperable NSCLC and sufficient tumor tissue for ERCC1 analysis, who had received carboplatin and gemcitabine as first-line treatment.

Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non–Small-Cell Lung Cancer The aim of ...

Andrews, A.D., Barrett, S.F., Yoder, F.W., and Robbins, J.H. 1978. Cockayne's syndrome fibroblasts have increased sensitivity to ultraviolet light but normal rates of ...